(Q53908001)

22 May 2018

title

The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. (English)

1 reference

22 May 2018

main subject

Helicobacter pylori

0 references

antibiotic resistance

1 reference

2

1 reference

22 May 2018

author name string

Savarino V

1

1 reference

22 May 2018

Pivari M

3

1 reference

22 May 2018

Bisso G

4

1 reference

22 May 2018

Raffaella Mele M

5

1 reference

22 May 2018

Bilardi C

6

1 reference

22 May 2018

Borro P

7

1 reference

22 May 2018

Dulbecco P

8

1 reference

22 May 2018

Tessieri L

9

1 reference

22 May 2018

Mansi C

10

1 reference

22 May 2018

Borgonovo G

11

1 reference

22 May 2018

De Salvo L

12

1 reference

22 May 2018

Vigneri S

13

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

22 May 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

22 May 2018

volume

14

1 reference

22 May 2018

issue

7

1 reference

22 May 2018

page(s)

893-900

1 reference

22 May 2018

A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Antibiotic resistance in Helicobacter pylori: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Treatment of Helicobacter pylori infection: a review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Eradication of Helicobacter pylori: an objective assessment of current therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Treating Helicobacter pylori--the best is yet to come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00780.X

10.1046/J.1365-2036.2000.00780.X

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018